View Older Stories
-
Acadia Healthcare (ACHC) PT Lowered to $22 at Guggenheim
-
Acadia Healthcare, Peloton Mentioned as Positive by Greenlight's Einhorn
-
Jefferies Downgrades Acadia Healthcare (ACHC) to Hold
-
Acadia Healthcare (ACHC) PT Lowered to $22 at TD Cowen
-
Acadia Healthcare (ACHC) PT Lowered to $17 at RBC Capital
-
Acadia Healthcare (ACHC) Reiterated at Neutral by Cantor Fitzgerald
-
Acadia Healthcare's (ACHC) Lowered Guidance Thrice - Cantor Fitzgerald
-
Acadia Healthcare (ACHC) PT Lowered at KeyBanc Following Another Guidance Cut
-
Acadia Healthcare (ACHC) PT Lowered to $17 at Cantor Fitzgerald
-
Leerink Partners Downgrades Acadia Healthcare (ACHC) to Market Perform
-
BofA Securities DowngradesAcadia Healthcare (ACHC) to Underperform
-
Acadia Healthcare (ACHC) PT Lowered to $19 at RBC Capital
-
Mizuho on Acadia Healthcare (ACHC): 'lack of EPS visibility will remain a valuation overhang on the stock in the near-term'
-
Acadia Healthcare cuts 2025 guidance on higher liability costs
-
Acadia Healthcare (ACHC) PT Lowered to $30 at KeyBanc
-
Acadia Healthcare (ACHC) PT Lowered to $25 at Raymond James
-
Acadia Healthcare (ACHC) PT Lowered at RBC Capital Amid Reimbursement Headwinds
-
Acadia Healthcare (ACHC) PT Lowered to $22 at Cantor Fitzgerald
-
Acadia Healthcare (ACHC) Tops Q3 EPS by 5c ; Offers Guidance
-
'Acadia Healthcare (ACHC) Prepared for Another Miss With 3Q'; PT Lowered at KeyBanc
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Acadia Healthcare (ACHC) PT Raised to $30 at Raymond James
-
UBS Reiterates Buy Rating on Acadia Healthcare (ACHC); Q3, FY25 Estimates Adjusted
-
Acadia Healthcare cuts 2026 capital spending guidance, adds beds
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
ACHC hires Goldman Sachs and JPMorgan as financial advisors
-
Engine Capital urges Acadia Healthcare board changes
-
Activist Engine Capital Has ~3% Stake In Acadia Healthcare (ACHC) - FT
-
BofA Securities Downgrades Acadia Healthcare (ACHC) to Neutral
-
Acadia Healthcare (ACHC) PT Lowered to $22 at Mizuho
-
Raymond James Downgrades Acadia Healthcare (ACHC) to Outperform 'to Balance Inexpensive Valuation vs. FCF Concerns'
-
Acadia Healthcare (ACHC) PT Lowered to $28 at RBC Capital as 'Medicaid Volume Weighs on Outlook'
-
Acadia Healthcare (ACHC) PT Lowered to $31 at UBS
-
Acadia Healthcare (ACHC) PT Lowered to $29 at Guggenheim
-
Acadia Healthcare (ACHC) Tops Q2 EPS by 13c ; Offers Guidance
-
UBS Reiterates Buy Rating on Acadia Healthcare (ACHC)
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
RBC Capital on Acadia Healthcare (ACHC): 'New LT Growth Targets Reflect Longer De Novo Ramp'
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Raymond James on Acadia Healthcare (ACHC) Post Q1 2025 Earnings: '1Q Not a Meltdown, But 2H Ramp Will be Focus'
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Acadia Healthcare (ACHC) PT Lowered to $32 at Mizuho
-
Acadia Healthcare (ACHC) PT Lowered to $55 at KeyBanc
-
Acadia Healthcare (ACHC) Tops Q1 EPS by 1c, Misses on Revenue; Offers FY25 Revenue Guidance
-
Guggenheim Starts Acadia Healthcare (ACHC) at Buy
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Given contract opportunity Caid stocks likely undervalued, says Cantor Fitzgerald
-
Raymond James Reiterates Strong Buy Rating on Acadia Healthcare (ACHC)
-
Acadia Healthcare (ACHC) PT Lowered to $37 at Mizuho

